Adjuvant Zoledronic Acid Reduces Disease Recurrence in Breast Cancer: Antitumor Effects on the Seed and the Soil

E-ISSN： 1875-6301|7|2|111-118

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.7, Iss.2, 2011-05, pp. : 111-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pain Control with Zoledronic Acid in Patients with Breast Cancer and Metastatic Bone Disease

By Cinzia Nigro Michela Donadio Mara Ardine Alessandra Beano Marinella Mistrangelo Zaira Coccorullo Oscar Bertetto

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 257-263

Adis International

Access to resources Recommend Favorite

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer

By Coleman R.

Breast Cancer Research and Treatment, Vol. 127, Iss. 2, 2011-06 ,pp. : 429-438

Springer Publishing Company

Access to resources Recommend Favorite

Jaw complications in breast and prostate cancer patients treated with zoledronic acid

By Ortega C. Faggiuolo R. Vormola R. Montemurro F. Nanni D. Goia F. Aglietta M.

Acta Oncologica, Vol. 45, Iss. 2, 2006-03 ,pp. : 216-217

Informa Healthcare

Access to resources Recommend Favorite

Relevance of Micrometastases and Targeting the Bone Marrow Niche with Zoledronic Acid in Breast Cancer

Current Cancer Therapy Reviews, Vol. 8, Iss. 2, 2012-05 ,pp. : 152-160

Bentham Science Publishers

Access to resources Recommend Favorite

Zoledronic acid enhances antitumor efficacy of liposomal doxorubicin

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 211-219

Spandidos Publications

Access to resources Recommend Favorite